This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie.

Amplifying the patient voice is essential for the success of clinical trials. Learn why it is crucial for patient engagement, recruitment, and overall trial success, and how it can address ...

Roche is petitioning the US administration for an exemption from tariffs for pharmaceuticals, arguing there is no trade imbalance in its US business.

The US has launched a national security probe into the national security implications of importing pharmaceuticals, seen as a precursor to tariffs.

Two impressive studies in lung cancer and another in breast cancer made Sunday a stellar day for AstraZeneca at the ASCO congress. Three of the group’s top cancer drugs were on display – EGFR ...

Sofinnova Partners has raised €165m for its new biotech fund and backed three startups working on Alzheimer's, fibrotic diseases, and cell therapies ...

The BIOSECURE Act is a proposed legislation that reflects the current strained US-Chinese relations, impacting biotech cooperation. Learn more about the implications and challenges.

RFK Jr names eight members of the CDC's vaccine panel, some known for contrarian views on immunisation, after ousting all 17 of their predecessors.

President Trump is rumoured to be resurrecting a policy that would see drug prices offered to federal programmes tied to those offered overseas ...

Fast-Track Your mRNA-Based Therapeutics & Vaccines from Discovery to Commercialisation by Ensuring Targeted Delivery, Durability & Tolerable Immunogenicity Across All Disease Indications As mRNA ...

Shionogi has added to its antibiotics pipeline by taking an option on a preclinical-stage candidate from BioVersys for non-tuberculous mycobacteria.

We interview five healthcare professionals to get honest feedback on their views of pharma. First up is a male consultant who specialises in anaesthetics. To coincide with our medical ...